Does FFAR4 agonism have therapeutic potential in cardiometabolic disease?

Abigail C Lay*

*Corresponding author for this work

Research output: Contribution to journalComment/debate (Academic Journal)peer-review

8 Downloads (Pure)
Original languageEnglish
Article numberbqab145
JournalEndocrinology
Volume162
Issue number10
Early online date20 Jul 2021
DOIs
Publication statusE-pub ahead of print - 20 Jul 2021

Keywords

  • FFAR4
  • GPR120
  • diabetes
  • obesity
  • metabolic syndrome
  • cardiometabolic disease
  • vascular disease
  • atherosclerosis
  • CVD

Cite this